Using highly variable warfarin dosing to identify patients at risk for adverse events

被引:0
作者
Lyndonna Marrast
Mary Evans
Al Ozonoff
Lori E Henault
Adam J Rose
机构
[1] Boston University School of Medicine,Department of Medicine
[2] Boston Medical Center,Biostatistics Section
[3] Children's Hospital of Boston,Center for Health Quality, Outcomes, and Economic Research
[4] Bedford VA Medical Center,undefined
关键词
anticoagulants; dose variability; medication therapy management; risk factors; warfarin.;
D O I
10.1186/1477-9560-9-14
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 178 条
  • [1] Ansell J(2008)Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 160S-198S
  • [2] Hirsh J(2008)Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 593S-629S
  • [3] Hylek E(2008)Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 546S-592S
  • [4] Jacobson A(2008)Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 454S-545S
  • [5] Crowther M(1994)Interactions of warfarin with drugs and food Ann Intern Med 121 676-683
  • [6] Palareti G(2005)Systematic overview of warfarin and its drug and food interactions Arch Intern Med 165 1095-1106
  • [7] Salem DN(2008)Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 257S-298S
  • [8] O'Gara PT(2003)Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis Ann Intern Med 139 893-900
  • [9] Madias C(2009)The Epidemiology of Sub-Therapeutic Anticoagulation in the United States Circ Cardiovasc Qual Outcomes 2 591-597
  • [10] Pauker SG(2007)Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V Arch Intern Med 167 239-245